🔎 Trials Near Me

Akèy › Kansè pwostat rezistan a kastasyon › Massachusetts › Boston

Etid klinik pou Kansè pwostat rezistan a kastasyon nan Boston, MA

5 etid pou Kansè pwostat rezistan a kastasyon ap chèche patisipan nan sit nan ak bò kote Boston (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer

Ap rekriteFaz 3
  • Massachusetts General, Boston
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT07225946

A Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)

Ap rekriteFaz 3
  • Dana Farber Cancer Institute, Boston
Laj 18 ak plis · Gason · Mizajou Sep 25, 2026 · NCT07164443

A Study in Patients With Metastatic Castration-Resistant Prostate Cancer

Ap rekriteFaz 1
  • Massachusetts General Hospital, Boston
  • Dana Farber Cancer Institute, Boston
Laj 18 ak plis · Gason · Mizajou Sep 24, 2026 · NCT07719361

A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas

Ap rekriteFaz 1/2
  • Massachusetts General Hospital, Boston
Laj 18 ak plis · Tout sèks · Mizajou Aug 19, 2026 · NCT04104776

A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer

Ap rekriteFaz 1
  • Dana-Farber Cancer Institute, Boston
Laj 18 ak plis · Gason · Mizajou Aug 10, 2026 · NCT06067841

Etid Kansè pwostat rezistan a kastasyon nan lòt vil

Lòt etid nan Boston

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.